Analia S. Loria

1.3k total citations
54 papers, 950 citations indexed

About

Analia S. Loria is a scholar working on Pediatrics, Perinatology and Child Health, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Analia S. Loria has authored 54 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pediatrics, Perinatology and Child Health, 20 papers in Physiology and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Analia S. Loria's work include Birth, Development, and Health (32 papers), Stress Responses and Cortisol (17 papers) and Adipose Tissue and Metabolism (13 papers). Analia S. Loria is often cited by papers focused on Birth, Development, and Health (32 papers), Stress Responses and Cortisol (17 papers) and Adipose Tissue and Metabolism (13 papers). Analia S. Loria collaborates with scholars based in United States, Spain and Argentina. Analia S. Loria's co-authors include Jennifer S. Pollock, David M. Pollock, Margaret Murphy, F. Javier Salazar, Danny M. Cohn, Virginia Reverte, Fara Sáez, Dao H. Ho, Dianne Cohn and Gerard D’Angelo and has published in prestigious journals such as Circulation, Physiological Reviews and Diabetes.

In The Last Decade

Analia S. Loria

49 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Analia S. Loria United States 22 433 225 221 201 162 54 950
Christine Laborie France 20 714 1.6× 170 0.8× 452 2.0× 72 0.4× 211 1.3× 41 1.4k
Carmen Campino Chile 22 292 0.7× 116 0.5× 259 1.2× 127 0.6× 66 0.4× 67 1.4k
Christina Lazaropoulou Greece 17 148 0.3× 150 0.7× 147 0.7× 32 0.2× 38 0.2× 29 835
D. Haack Germany 20 145 0.3× 267 1.2× 152 0.7× 209 1.0× 36 0.2× 51 1.5k
Serenella Arangino Italy 17 111 0.3× 50 0.2× 233 1.1× 193 1.0× 42 0.3× 32 970
M Ingram United Kingdom 19 96 0.2× 237 1.1× 138 0.6× 284 1.4× 25 0.2× 31 1.3k
Shona L. Kirk United Kingdom 7 290 0.7× 23 0.1× 345 1.6× 39 0.2× 122 0.8× 7 975
M Cacciari Italy 9 47 0.1× 97 0.4× 217 1.0× 146 0.7× 53 0.3× 28 1.0k
Suzette Y. Osei United States 17 84 0.2× 59 0.3× 665 3.0× 388 1.9× 34 0.2× 24 1.9k
Cristina Lopez‐Lopez Switzerland 11 120 0.3× 15 0.1× 268 1.2× 87 0.4× 119 0.7× 22 891

Countries citing papers authored by Analia S. Loria

Since Specialization
Citations

This map shows the geographic impact of Analia S. Loria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Analia S. Loria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Analia S. Loria more than expected).

Fields of papers citing papers by Analia S. Loria

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Analia S. Loria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Analia S. Loria. The network helps show where Analia S. Loria may publish in the future.

Co-authorship network of co-authors of Analia S. Loria

This figure shows the co-authorship network connecting the top 25 collaborators of Analia S. Loria. A scholar is included among the top collaborators of Analia S. Loria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Analia S. Loria. Analia S. Loria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Warrington, Junie P., Helen E. Collins, Sandra T. Davidge, et al.. (2024). Guidelines for in vivo models of developmental programming of cardiovascular disease risk. American Journal of Physiology-Heart and Circulatory Physiology. 327(1). H221–H241. 1 indexed citations
4.
Park, Sehyung, Lindsey R. Conroy, Harrison A. Clarke, et al.. (2024). Knockdown of ketohexokinase versus inhibition of its kinase activity exert divergent effects on fructose metabolism. JCI Insight. 9(23). 5 indexed citations
5.
Osborn, Jeffrey L., et al.. (2024). Human soluble prorenin receptor expressed in mouse renal collecting duct shows sex-specific effect on cardiorenal function. American Journal of Physiology-Renal Physiology. 326(4). F611–F621. 1 indexed citations
6.
Lin, An‐Hsuan, Scott M. Gordon, Ming Gong, et al.. (2023). Prenatal Morphine Exposure Increases Cardiovascular Disease Risk and Programs Neurogenic Hypertension in the Adult Offspring. Hypertension. 80(6). 1283–1296. 6 indexed citations
7.
Giani, Jorge F., et al.. (2023). Obese Male Mice Exposed to Early Life Stress Display Sympathetic Activation and Hypertension Independent of Circulating Angiotensin II. Journal of the American Heart Association. 13(1). e029511–e029511. 3 indexed citations
8.
9.
Dalmasso, Carolina, Mei Xu, Barbara S. Nikolajczyk, et al.. (2022). Early life stress exacerbates obesity in adult female mice via mineralocorticoid receptor-dependent increases in adipocyte triglyceride and glycerol content. Life Sciences. 304. 120718–120718. 11 indexed citations
10.
Lei, Feitong, et al.. (2022). Sex and race define the effects of adverse childhood experiences on self-reported BMI and metabolic health biomarkers. Biology of Sex Differences. 13(1). 29–29. 8 indexed citations
11.
Dalmasso, Carolina, et al.. (2021). Epididymal Fat-Derived Sympathoexcitatory Signals Exacerbate Neurogenic Hypertension in Obese Male Mice Exposed to Early Life Stress. Hypertension. 78(5). 1434–1449. 8 indexed citations
12.
Verma, Nirmal, Miao Liu, Analia S. Loria, et al.. (2019). Diabetic microcirculatory disturbances and pathologic erythropoiesis are provoked by deposition of amyloid-forming amylin in red blood cells and capillaries. Kidney International. 97(1). 143–155. 31 indexed citations
13.
Cohn, Dianne, et al.. (2018). Losartan prevents the elevation of blood pressure in adipose-PRR deficient female mice while elevated circulating sPRR activates the renin-angiotensin system. American Journal of Physiology-Heart and Circulatory Physiology. 316(3). H506–H515. 23 indexed citations
14.
Murphy, Margaret, Danny M. Cohn, & Analia S. Loria. (2016). Developmental origins of cardiovascular disease: Impact of early life stress in humans and rodents. Neuroscience & Biobehavioral Reviews. 74(Pt B). 453–465. 91 indexed citations
15.
Srodulski, Sarah, Analia S. Loria, Sanda Despa, & Florin Despa. (2014). Abstract 13963: Hyperamylinemia, a Potential Therapeutic Target in Diabetic Cardiorenal Syndrome. Circulation. 130. 2 indexed citations
16.
Reverte, Virginia, et al.. (2013). COX2 inhibition during nephrogenic period induces ANG II hypertension and sex-dependent changes in renal function during aging. American Journal of Physiology-Renal Physiology. 306(5). F534–F541. 6 indexed citations
17.
Loria, Analia S., David M. Pollock, & Jennifer S. Pollock. (2009). Early Life Stress Sensitizes Rats to Angiotensin II–Induced Hypertension and Vascular Inflammation in Adult Life. Hypertension. 55(2). 494–499. 60 indexed citations
18.
Salazar, F. Javier, Virginia Reverte, Fara Sáez, et al.. (2008). Age- and Sodium-Sensitive Hypertension and Sex-Dependent Renal Changes in Rats With a Reduced Nephron Number. Hypertension. 51(4). 1184–1189. 28 indexed citations
19.
Loria, Analia S., Virginia Reverte, F. Javier Salazar, et al.. (2007). Changes in renal hemodynamics and excretory function induced by a reduction of ANG II effects during renal development. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 293(2). R695–R700. 24 indexed citations
20.
Loria, Analia S., et al.. (2004). Role of nitric oxide pathway in hypotensive and renal effects of furosemide during extracellular volume expansion. Journal of Hypertension. 22(8). 1561–1569. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Laborie Breakdown of academic impact, for papers by Carmen Campino Breakdown of academic impact, for papers by Christina Lazaropoulou Breakdown of academic impact, for papers by D. Haack Breakdown of academic impact, for papers by Serenella Arangino Breakdown of academic impact, for papers by M Ingram Breakdown of academic impact, for papers by Shona L. Kirk Breakdown of academic impact, for papers by M Cacciari Breakdown of academic impact, for papers by Suzette Y. Osei Breakdown of academic impact, for papers by Cristina Lopez‐Lopez
Rankless by CCL
2026